These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24909809)

  • 21. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.
    Briot K; Gossec L; Kolta S; Dougados M; Roux C
    J Rheumatol; 2008 May; 35(5):855-61. PubMed ID: 18381782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton.
    Klingberg E; Geijer M; Göthlin J; Mellström D; Lorentzon M; Hilme E; Hedberg M; Carlsten H; Forsblad-D'Elia H
    J Rheumatol; 2012 Oct; 39(10):1987-95. PubMed ID: 22896024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
    Baraliakos X; Haibel H; Listing J; Sieper J; Braun J
    Ann Rheum Dis; 2014 Apr; 73(4):710-5. PubMed ID: 23505240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes?
    Kaya A; Ozgocmen S; Kamanli A; Ardicoglu O
    Med Princ Pract; 2009; 18(6):470-6. PubMed ID: 19797924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
    Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
    J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
    Kim HR; Lee SH; Kim HY
    Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
    Lim Y; Jo K; Ha HS; Yim HW; Yoon KH; Lee WC; Son HY; Baek KH; Kang MI
    Osteoporos Int; 2017 Apr; 28(4):1453-1459. PubMed ID: 28083665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis.
    Donnelly S; Doyle DV; Denton A; Rolfe I; McCloskey EV; Spector TD
    Ann Rheum Dis; 1994 Feb; 53(2):117-21. PubMed ID: 8129456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of researches, which assess bone mineral density and bone metabolism in patients with ankylosing spondylitis, in detecting osteoporosis].
    Przepiera-Bedzak H
    Ann Acad Med Stetin; 2007; 53(3):39-47. PubMed ID: 18595484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis.
    Arends S; Wink F; Veneberg J; Bos R; van Roon E; van der Veer E; Maas F; Spoorenberg A
    Br J Clin Pharmacol; 2021 Feb; 87(2):644-651. PubMed ID: 32530102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis.
    Ulu MA; Batmaz İ; Dilek B; Çevik R
    Chin Med J (Engl); 2014; 127(15):2740-7. PubMed ID: 25146606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
    Marciniak C; Gabet J; Lee J; Ma M; Brander K; Wysocki N
    Osteoporos Int; 2016 Apr; 27(4):1477-1484. PubMed ID: 26576540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis.
    Gulyás K; Horváth Á; Végh E; Pusztai A; Szentpétery Á; Pethö Z; Váncsa A; Bodnár N; Csomor P; Hamar A; Bodoki L; Bhattoa HP; Juhász B; Nagy Z; Hodosi K; Karosi T; FitzGerald O; Szücs G; Szekanecz Z; Szamosi S; Szántó S
    Clin Rheumatol; 2020 Jan; 39(1):167-175. PubMed ID: 31522318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis-A prospective study.
    Magrey MN; Lewis S; Asim Khan M
    Semin Arthritis Rheum; 2016 Aug; 46(1):88-94. PubMed ID: 27162010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U; Teichmann J; Müller-Ladner U; Strunk J
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study.
    Maillefert JF; Aho LS; El Maghraoui A; Dougados M; Roux C
    Osteoporos Int; 2001; 12(7):605-9. PubMed ID: 11527060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review.
    van der Weijden MA; Claushuis TA; Nazari T; Lems WF; Dijkmans BA; van der Horst-Bruinsma IE
    Clin Rheumatol; 2012 Nov; 31(11):1529-35. PubMed ID: 22706444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of tumour necrosis factor α blockade on bone metabolism in chronic inflammatory joint diseases].
    Aguilar Del Rey FJ; García Portales R; Haro Liger M; Rodríguez Andreu J; Casals Sánchez JL; Pérez González R
    Med Clin (Barc); 2016 Jul; 147(2):56-62. PubMed ID: 27209224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis.
    Farsinejad-Marj M; Saneei P; Esmaillzadeh A
    Osteoporos Int; 2016 Apr; 27(4):1389-1399. PubMed ID: 26556742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-α blocking therapy.
    Maas F; Spoorenberg A; Brouwer E; Schilder AM; Chaudhry RN; Wink F; Bootsma H; van der Veer E; Arends S
    Clin Exp Rheumatol; 2016; 34(2):191-9. PubMed ID: 26886385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.